Novo Nordisk rolls out long-awaited Tresiba, aiming for blockbuster market share

Tracy Staton Novo Nordisk finally launched its next-gen diabetes treatment Tresiba in the U.S., approved by the FDA last September. The Danish drugmaker has high hopes ...

Biotech IPOs boom in Q2, enjoying a long-awaited embrace from investors

John Carroll The National Venture Capital Association in league with Thomson Reuters has provided some data showing that the second quarter of this year offered the largest number of ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS